Milwaukee – October 12, 2026 -- A. O. Smith Corporation (NYSE: AOS) raised its quarterly cash dividend rate 6% to $0.38 per share, extending a record of more than 30 consecutive years of dividend increases.

Board approves increase for both Common and Class A Common Stock

The board of directors approved the higher rate, which applies to the company's Common Stock and Class A Common Stock.

Payment set for Nov. 16 to holders of record on Oct. 30, 2026

The dividend is payable on Monday, Nov. 16, to shareholders of record as of Friday, Oct. 30, 2026.

Chairman and CEO Shafer points to cash generation and business resilience

Steve Shafer, chairman and chief executive officer, said the 30-plus-year run of annual increases reflects the resilience of the business and the strength of its cash generation. He added that the increase reflects the company's confidence in its future.

Paris – October 12, 2026 -- Changan Automobile will launch the NEVO Q05 in Spain and Italy by the first quarter of 2027, after the model made its European debut at Mondial de l'Auto 2026.

Changan adds NEVO line to DEEPAL a year after its European entry

The NEVO line follows the introduction of the DEEPAL line in Europe last year. Changan says NEVO has served more than one million families globally. The NEVO Q06 is planned as a further addition, though the source gives no launch date.

Changan's European portfolio now spans the CHANGAN brand, its DEEPAL and NEVO lines, and AVATR.

Plug-in hybrid versions widen the DEEPAL range

The DEEPAL S05 and S07 are already on sale in Europe in battery-electric versions. The left-hand-drive S05 PHEV has now joined them. The S07 PHEV will be introduced across major European markets later this year.

Lehi – October 12, 2026 -- Gargle, Inc., a dental-focused digital marketing company, is extending its search measurement to cover how dental practices appear in AI-generated answers on ChatGPT, Gemini and Google's AI search experiences, alongside traditional Google rankings.

The company delivers the analysis through its AI Search & Marketing Visibility Report and ongoing search optimization services. Both are designed to show practices where they stand across traditional and AI-driven discovery channels.

Gargle bundles five visibility areas into one reporting framework

The approach evaluates the following areas together:

CHICAGO – October 12, 2026 -- CME Group has completed initial performance testing for CME Globex in the cloud and reports faster round-trip times for trading, along with an accelerated build of its Aurora Cloud Region and co-location facility.

Aurora facility is ahead of schedule, with client testing targeted for mid-2027

The Aurora facility will host Google Cloud's new specialized platform for trading CME Group markets, which the exchange operator describes as industry-first. CME Group targets mid-2027 for client testing. Its Dallas disaster recovery facility has been open for testing since June 2026.

Livestock markets will migrate from Aurora in late 2027, skipping Dallas

CME Group will move its livestock markets to the cloud out of the Aurora Cloud Region in late 2027. The previously planned interim relocation to Dallas is no longer necessary.

Philadelphia – October 12, 2026 -- Matson, Inc. (NYSE: MATX) and Hanwha Philly Shipyard, Inc. (HPSI) christened 'Makua' on October 10, the first of three Jones Act-compliant containerships worth approximately $1 billion in total, with delivery scheduled for the first quarter of 2027.

Three newbuilds will replace three vessels in Hawaii and CLX services

The ships are being built for Matson's China-Long Beach Express (CLX) and Hawaii services. They will replace three vessels currently deployed on those routes. The second ship is scheduled for delivery in the third quarter of 2027, and the third is expected in the second quarter of 2028.

Matson Chairman and CEO Matt Cox said the three additions over the next 18 months will improve operating efficiencies and reliability and increase capacity in the Hawaii and CLX services.

Philadelphia – October 12, 2026 -- Breakthrough T1D, formerly JDRF, closed its inaugural Clinical & Research Congress after more than 80 sessions and scheduled the 2027 edition for Washington, D.C., October 15-17, 2027.

The congress ran October 9-11, 2026, in Philadelphia. It brought together clinicians, researchers, scientists, healthcare professionals, industry leaders, people with lived experience and community advocates.

Sessions span immunotherapies, islet cell therapies and AI-driven tools

The program covered endocrinology, discovery science and immunotherapies, and emerging technologies including AI and digital twins. It also addressed islet cell and disease-modifying therapies, and access to care for the type 1 diabetes (T1D) community.

Chicago – October 12, 2026 -- Equity LifeStyle Properties (NYSE: ELS) will release its third quarter 2026 earnings on Tuesday, October 20, after market close, with a management conference call and audio webcast to follow on Wednesday, October 21, at 11:00 a.m. Eastern Time.

ELS management will discuss operating and financial results on October 21

The executive management team will host the call the morning after the release. Research analysts and other interested parties must register at least fifteen minutes before the scheduled start to receive dial-in details. The live webcast and a replay will be available in the Investor Relations section of the company's website under Events.

Portfolio spans 453 properties and 173,559 sites as of June 30, 2026

The real estate investment trust owns or has an interest in 453 properties, predominantly in the United States. Those properties comprise 173,559 sites as of June 30, 2026.

Raleigh – October 12, 2026 -- Bandwidth Inc. (NASDAQ: BAND) will publish its financial results for the third quarter ended September 30, 2026, before market open on Thursday, October 29, 2026.

Bandwidth schedules an 8:00 a.m. ET call on October 29

Management will discuss the quarter on a conference call at 8:00 a.m. Eastern Time on the same day. A live webcast will run on the Investor Relations section of the company's website, and a replay will be posted there shortly after the call ends.

Domestic participants can dial in at 844-481-2707. International callers can use 412-317-0663.

Replay stays available through November 5, 2026

A telephone replay will run from the end of the call through Thursday, November 5, 2026. U.S. callers can dial 855-669-9658, and callers outside the U.S. can dial 412-317-0088. Both lines require passcode 4828018.

The announcement gives no financial figures or guidance for the quarter.

Lake Oswego – October 12, 2026 -- The Greenbrier Companies (NYSE:GBX) will report fourth-quarter fiscal 2026 results after market close on Monday, October 26, 2026, the railcar maker announced.

Greenbrier schedules management call for 2:00 p.m. PDT on results day

The company will host a live conference call at 2:00 p.m. PDT on October 26. Shareholders and other interested parties can listen via webcast or by dial-in.

The webcast and the earnings release will be available on the company's website. The webcast will be archived for 30 days.

Dial-in lines open for domestic and international callers

Domestic callers can join at 1-888-317-6003, while international callers can use 1-412-317-6061. The passcode is 5771220. Greenbrier asks participants to dial in 10-15 minutes before the start to ensure a proper connection.

Friendswood – October 12, 2026 -- Management recommendations changed in line with TissueCypher risk classifications for 96% of patients in a multi-center Barrett's esophagus cohort, according to data Castle Biosciences (Nasdaq: CSTL) is presenting at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting in Nashville, Oct. 9-14.

The company is presenting three studies: two case reports and one multi-center cohort study. All three examine whether the molecular test adds risk information beyond histopathology.

TissueCypher and clinicopathologic scoring agreed only slightly in the multi-center cohort

The cohort study (P5192) compared TissueCypher with the Progression in Barrett's (PIB) clinicopathologic approach and found only slight agreement (Cohen's κ = 0.04). TissueCypher classified 83% of patients as low risk and 17% as intermediate/high risk. The PIB score classified 31% as low risk and 69% as intermediate/high risk.